- Associated Press•8 hours ago
U.S. regulators on Tuesday approved the first lower-cost version of Enbrel, a blockbuster anti-inflammatory drug from Amgen that is among the top-selling drugs in the world.
- Market Realist•9 hours ago
StrataGraft, if approved, will be the first biological off-the-shelf skin substitute for treating severe burns.
- Market Realist•11 hours ago
Johnson & Johnson (JNJ) announced a quarterly cash dividend of $0.80 per share on July 18, 2016, payable on September 6, 2016. This is the same as the previous quarter.
Johnson & Johnson (JNJ)
NYSE - NYSE Real Time Price. Currency in USD
|Day's Range||119.26 - 120.67|
|52wk Range||89.90 - 126.07|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||22.26|
|Avg Vol (3m)||6,808,166|
|Dividend & Yield||3.20 (2.67%)|